Table 3 All-causality treatment-emergent adverse events, n (%)*
| Â | LTFC N = 125 | LTuFC N = 124 |
|---|---|---|
Subjects with ≥1 adverse event | 14 (11.2) | 8 (6.5) |
Subjects with ≥1 severe adverse Event | 0 | 0 |
Subjects with ≥1 serious adverse Event | 0 | 0 |
Conjunctival hyperemia | 9 (7.2) | 6 (4.8) |
Visual field defect (mild) | 3 (2.4) | 0 |
Eye irritation | 1 (0.8) | 0 |
Eyelid cyst | 1 (0.8) | 0 |
Eyelid disorder | 1 (0.8) | 0 |
Vision blurred | 1 (0.8) | 0 |
Right bundle branch block | 1 (0.8) | 0 |
Chest pain | 0 | 1 (0.8) |
Viral conjunctivitis | 0 | 1 (0.8) |